Legal Challenges to Healthcare Reform Threaten Biopharmaceutical Legislation

31 March 2011 Publication
Authors: Antoinette F. Konski

Genetic Engineering & Biotechnology News

Foley Partner Antoinette Konski authored an article that appeared in Genetic Engineering & Biotechnology News on March 31, 2011 titled "Legal Challenges to Healthcare Reform Threaten Biopharmaceutical Legislation." Konski discusses the legal challenges that stand to negate several provisions in the Patient Protection and Affordable Care Act that support domestic biopharmaceutical R&D, stating that some mandates of the Act could help the development of personalized medicine, comparative effectiveness research and regulation of biosimilars. She adds that these benefits to the biopharmaceutical industry would be lost if the Act is declared unconstitutional, noting that there is no guarantee that any replacement legislation would contain identical or similar provisions of benefit to the industry.


RCE PTA Carve-Out Resumes After Interference
18 September 2019
The Ninth Circuit Expected to Rule that Doctors Can Be Wrong in the Winter v. Gardens False Claims Act Case
18 September 2019
Legal News: Government Enforcement Defense & Investigations
Upcoming Webinar: Maximizing Solar Tax Credits - Navigating the Start of Construction Rules (Part 1)
17 September 2019
Renewable Energy Outlook
When Birds Finally Find a Nest
17 September 2019
Dashboard Insights
Lacktman, Ferrante Cited in mHealth Intelligence About Ryan Haight Act
19 September 2019
mHealth Intelligence
Tinnen Discusses How Viewpoint Diversity Helps Businesses Thrive
18 September 2019
Vernaglia Comments on AHA v Azar Decision
18 September 2019
MedPage Today
Lach Comments on Launch of New Group
16 September 2019
BizTimes Milwaukee
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.